JPWO2021100614A1 - - Google Patents
Info
- Publication number
- JPWO2021100614A1 JPWO2021100614A1 JP2021558343A JP2021558343A JPWO2021100614A1 JP WO2021100614 A1 JPWO2021100614 A1 JP WO2021100614A1 JP 2021558343 A JP2021558343 A JP 2021558343A JP 2021558343 A JP2021558343 A JP 2021558343A JP WO2021100614 A1 JPWO2021100614 A1 JP WO2021100614A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Food Science & Technology (AREA)
- Psychiatry (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Toxicology (AREA)
- Botany (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019208777 | 2019-11-19 | ||
| JP2019208777 | 2019-11-19 | ||
| PCT/JP2020/042317 WO2021100614A1 (ja) | 2019-11-19 | 2020-11-12 | 大豆ペプチド及び/又はコラーゲンペプチド含有神経心理学的機能改善剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2021100614A1 true JPWO2021100614A1 (cg-RX-API-DMAC7.html) | 2021-05-27 |
| JPWO2021100614A5 JPWO2021100614A5 (cg-RX-API-DMAC7.html) | 2022-07-19 |
| JP7764992B2 JP7764992B2 (ja) | 2025-11-06 |
Family
ID=75981290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021558343A Active JP7764992B2 (ja) | 2019-11-19 | 2020-11-12 | 大豆ペプチド及び/又はコラーゲンペプチド含有神経心理学的機能改善剤 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP7764992B2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021100614A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022168413A1 (ja) * | 2021-02-04 | 2022-08-11 | ユーハ味覚糖株式会社 | デプレスタチン含有組成物の製造方法 |
| US20250059233A1 (en) * | 2021-12-15 | 2025-02-20 | Viage Therapeutics Inc. | Use of therapeutic peptides |
| JPWO2024117210A1 (cg-RX-API-DMAC7.html) * | 2022-12-01 | 2024-06-06 | ||
| WO2024259556A1 (en) * | 2023-06-19 | 2024-12-26 | Viage Therapeutics, Inc. | Uses of therapeutic peptides |
| EP4743102A1 (en) * | 2024-04-15 | 2026-05-20 | Rousselot BV | Collagen Peptide Composition and its Use in Reversing Neurological Disorders and Fibrosis |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010104364A (ja) * | 2009-09-18 | 2010-05-13 | Uha Mikakuto Co Ltd | 神経新生促進剤を含有する飲食品 |
| JP2011111440A (ja) * | 2009-11-30 | 2011-06-09 | Uha Mikakuto Co Ltd | 神経細胞分化促進剤 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101415724B (zh) * | 2003-06-30 | 2015-12-02 | 特拉维夫大学未来科技开发有限公司 | 肽、抗肽抗体以及用它们来诊断和治疗淀粉样蛋白相关疾病的方法 |
| BRPI0812768A2 (pt) * | 2007-06-08 | 2014-12-02 | Massachusetts Inst Technology | Igf para o tratamento de síndrome de rett e transtornos sinápticos. |
-
2020
- 2020-11-12 WO PCT/JP2020/042317 patent/WO2021100614A1/ja not_active Ceased
- 2020-11-12 JP JP2021558343A patent/JP7764992B2/ja active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010104364A (ja) * | 2009-09-18 | 2010-05-13 | Uha Mikakuto Co Ltd | 神経新生促進剤を含有する飲食品 |
| JP2011111440A (ja) * | 2009-11-30 | 2011-06-09 | Uha Mikakuto Co Ltd | 神経細胞分化促進剤 |
Non-Patent Citations (6)
| Title |
|---|
| KATAYAMA, S. ET AL.: "Oral Administration of Soy Peptides Suppresses Cognitive Decline by Induction of Neurotrophic Factor", J. AGRIC. FOOD CHEM., vol. 62, JPN6021003444, 2014, pages 3563 - 3569, XP055825528, ISSN: 0005540301, DOI: 10.1021/jf405416s * |
| MIZUSHIGE, T.: "Ginger-Degraded Collagen Hydrolysate Exhibits Antidepressant Activity in Mice", J. NUTR. SCI. VITAMINOL., vol. 65 (3), JPN6021003439, 30 June 2019 (2019-06-30), pages 251 - 257, ISSN: 0005540298 * |
| MORI, Y. ET AL.: "Characterization of soy-deprestatin, a novel orally active decapeptide that exerts antidepressant-l", FASEB J., vol. 32, JPN6021003441, 2018, pages 568 - 575, ISSN: 0005540299 * |
| PEI, X. ET AL.: "Marine collagen peptide isolated from Chum Salmon (Oncorhynchus keta) skin facilitates learning and", FOOD CHEMISTRY, vol. 118, JPN6021003437, 2010, pages 333 - 340, XP026497676, ISSN: 0005540297, DOI: 10.1016/j.foodchem.2009.04.120 * |
| 永井研迅 ほか: "コラーゲンペプチドPro-Hypの抗うつ作用", 第71回日本栄養・食糧学会大会講演要旨集, JPN6021003435, 2017, pages 207 - 2, ISSN: 0005540296 * |
| 鹿島康浩 ほか: "大豆由来ペプチド配合チュアブル錠が飲用者に与える心理的および生理的な影響評価について —ランダム化プ", JPN. PHARMACOL. THER.(薬理と治療), vol. 47 (9), JPN6021003443, 20 September 2019 (2019-09-20), pages 1425 - 1431, ISSN: 0005540300 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JP7764992B2 (ja) | 2025-11-06 |
| WO2021100614A1 (ja) | 2021-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112019017762A2 (cg-RX-API-DMAC7.html) | ||
| BR112021008711A2 (cg-RX-API-DMAC7.html) | ||
| BR112019016141A2 (cg-RX-API-DMAC7.html) | ||
| BR112021013944A2 (cg-RX-API-DMAC7.html) | ||
| BR112019016142A2 (cg-RX-API-DMAC7.html) | ||
| BR112019016138A2 (cg-RX-API-DMAC7.html) | ||
| BR112021012348A2 (cg-RX-API-DMAC7.html) | ||
| AT524962A5 (cg-RX-API-DMAC7.html) | ||
| BR112021013128A2 (cg-RX-API-DMAC7.html) | ||
| BR112019016136A2 (cg-RX-API-DMAC7.html) | ||
| BR102020025141B1 (pt) | Máquina elétrica girante eletronicamente comutada | |
| BR102020020816B1 (pt) | Veículo, e, método para controlar o movimento de ar através de um veículo com uma ventoinha do veículo | |
| BR102020020846B1 (pt) | Niveladora, e, método para serviço em uma niveladora | |
| BR102020018650B1 (pt) | Método para preparar óxido de cálcio usando um forno pré- aquecedor de suspensão de múltiplos estágios | |
| BR102020017390B1 (pt) | Bomba multifásica | |
| BR102020016297B1 (pt) | Bolsa de forro para um contentor e método para criar e prender uma bolsa de forro a um contentor | |
| BR102020011722B1 (pt) | Porta de tela para um pacote de radiadores | |
| BR102020005984B1 (pt) | Dispositivo de arranque-gerador combinado, e, conjunto de trem de acionamento | |
| BR102020005860B1 (pt) | Controle de obstrução para um implemento agrícola | |
| BR112021010564B1 (pt) | Sistema de armadilha para animais e método de monitoramento do mesmo | |
| BR112021014592B1 (pt) | Compostos fotosensibilizadores, métodos de fabricação e aplicação em plantas | |
| BR112021013954B1 (pt) | Sistema de cateter com confirmação da colocação do cateter dentro de uma veia | |
| BR112021013470B1 (pt) | Conector de acesso sem agulha para facilitar a entrega de instrumento a um conjunto de cateter | |
| BR102020000355B1 (pt) | Embreagem que tem dois estágios para aplicar torque variado entre um eixo de entrada e um eixo de saída | |
| BR102019027339B1 (pt) | Sistema de aspersão de água e difusor de sistema de aspersão de água |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A527 Effective date: 20220509 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220524 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230830 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240820 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20241021 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20241126 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20250304 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250603 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20250603 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20250916 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20251008 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7764992 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |